157 related articles for article (PubMed ID: 2196425)
1. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group III report: weight of evidence and quantitative evaluation of developmental neurotoxicity data.
Tyl RW; Sette WF
Neurotoxicol Teratol; 1990; 12(3):275-80. PubMed ID: 2196425
[TBL] [Abstract][Full Text] [Related]
2. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group II report: testing methods in developmental neurotoxicity for use in human risk assessment.
Buelke-Sam J; Mactutus CF
Neurotoxicol Teratol; 1990; 12(3):269-74. PubMed ID: 2196424
[TBL] [Abstract][Full Text] [Related]
3. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals.
Stanton ME; Spear LP
Neurotoxicol Teratol; 1990; 12(3):261-7. PubMed ID: 2115099
[TBL] [Abstract][Full Text] [Related]
4. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group IV report: triggers for developmental neurotoxicity testing.
Levine TE; Butcher RE
Neurotoxicol Teratol; 1990; 12(3):281-4. PubMed ID: 2196426
[TBL] [Abstract][Full Text] [Related]
5. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: summary and implications.
Francis EZ; Kimmel CA; Rees DC
Neurotoxicol Teratol; 1990; 12(3):285-92. PubMed ID: 2196427
[TBL] [Abstract][Full Text] [Related]
6. Scientific and regulatory issues relevant to assessing risk for developmental neurotoxicity: an overview.
Rees DC; Francis EZ; Kimmel CA
Neurotoxicol Teratol; 1990; 12(3):175-81. PubMed ID: 2196418
[TBL] [Abstract][Full Text] [Related]
7. Qualitative and quantitative comparability of human and animal developmental neurotoxicants: a workshop summary.
Rees DC; Francis EZ; Kimmel CA
Neurotoxicology; 1990; 11(2):257-69. PubMed ID: 1978270
[TBL] [Abstract][Full Text] [Related]
8. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies.
Crofton KM; Makris SL; Sette WF; Mendez E; Raffaele KC
Neurotoxicol Teratol; 2004; 26(3):345-52. PubMed ID: 15113596
[TBL] [Abstract][Full Text] [Related]
9. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing.
Kroes R; Galli C; Munro I; Schilter B; Tran L; Walker R; Würtzen G
Food Chem Toxicol; 2000; 38(2-3):255-312. PubMed ID: 10717364
[TBL] [Abstract][Full Text] [Related]
10. The need for developmental neurotoxicity studies in risk assessment for developmental toxicity.
Hass U
Reprod Toxicol; 2006 Aug; 22(2):148-56. PubMed ID: 16777374
[TBL] [Abstract][Full Text] [Related]
11. Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+PFOS) in rats: developmental neurotoxicity.
Butenhoff JL; Ehresman DJ; Chang SC; Parker GA; Stump DG
Reprod Toxicol; 2009 Jun; 27(3-4):319-330. PubMed ID: 19162172
[TBL] [Abstract][Full Text] [Related]
12. The comparative developmental neurotoxicity of lead in humans and animals.
Davis JM; Otto DA; Weil DE; Grant LD
Neurotoxicol Teratol; 1990; 12(3):215-29. PubMed ID: 2196421
[TBL] [Abstract][Full Text] [Related]
13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
14. Expanding the test set: Chemicals with potential to disrupt mammalian brain development.
Mundy WR; Padilla S; Breier JM; Crofton KM; Gilbert ME; Herr DW; Jensen KF; Radio NM; Raffaele KC; Schumacher K; Shafer TJ; Cowden J
Neurotoxicol Teratol; 2015; 52(Pt A):25-35. PubMed ID: 26476195
[TBL] [Abstract][Full Text] [Related]
15. Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals.
Burbacher TM; Rodier PM; Weiss B
Neurotoxicol Teratol; 1990; 12(3):191-202. PubMed ID: 2196419
[TBL] [Abstract][Full Text] [Related]
16. EPA's neurotoxicity risk assessment guidelines.
Boyes WK; Dourson ML; Patterson J; Tilson HA; Sette WF; MacPhail RC; Li AA; O'Donoghue JL
Fundam Appl Toxicol; 1997 Dec; 40(2):175-84. PubMed ID: 9441713
[TBL] [Abstract][Full Text] [Related]
17. Developmental neuropathology in DNT-studies--a sensitive tool for the detection and characterization of developmental neurotoxicants.
Kaufmann W; Gröters S
Reprod Toxicol; 2006 Aug; 22(2):196-213. PubMed ID: 16781841
[TBL] [Abstract][Full Text] [Related]
18. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research.
Kimmel CA
Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591
[TBL] [Abstract][Full Text] [Related]
19. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
20. Developmental neurotoxicity of anticonvulsants: human and animal evidence on phenytoin.
Adams J; Vorhees CV; Middaugh LD
Neurotoxicol Teratol; 1990; 12(3):203-14. PubMed ID: 2196420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
